University Hospital of Toulouse
Toulouse, 31059, France
NCT Number: NCT04663022
An unpublished study conducted at Toulouse University Hospital revealed that 30% of implanted children with Autism Spectrum Disorders abandon their implant, while 70% of them keep it. The aim of this study is to evaluate the causes of this disparity, which is much greater than in children with cochlear implants without associated Autism Spectrum Disorders. Our problem is as follows: do the sensory hypersensitivity and hyposensitivity of deaf children with Autism Spectrum Disorders have an effect on the expected results after a cochlear implantation from a language and auditory reaction point of view?
Looking for future studies?
Notify Me15 month–10 year
All sexes
Observational
Toulouse, 31059, France
The present study will specifically focus on the sensory profile of these children with Autism Spectrum Disorders, which could be the cause of these developmental difficulties in language and communication development.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
all children will complete the Dunn Sensory Profile questionnaire
Time frame: inclusion visit
To determine the sensory profile of implanted deaf children with autism spectrum disorders, each parent complete the questionnaire Dunn's sensory profile
University Hospital, Toulouse
Other
Acronym: PSIC-TSA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07639346
Deafness, Ear Diseases
Cairo, Egypt
View Trial DetailsNCT05993832
Deafness, Ear Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06492993
Cancer, Deafness
Washington D.C., District of Columbia, United States
View Trial DetailsNCT04563884
Deafness, Ear Diseases
Paris, France
View Trial Details